Gene expression profiles of human liver cells mediated by hepatitis B virus X protein

Acta Pharmacologica Sinica

Volumn 30, Issue 4, 2009, Pages 424-434

  Zhang, Wei Ying ^a   Xu, Fu Qing ^a   Shan, Chang Liang ^a   Xiang, Rong ^a   Ye, Li Hong ^a   Zhang, Xiao Dong ^a  

^a NANKAI UNIVERSITY   (China)

Author keywords

COX 2; HBx; Hepatitis B virus; Microarray; Proliferation

Indexed keywords

BROXURIDINE; CYCLINE; CYCLOOXYGENASE 2; HEPATITIS B VIRUS X PROTEIN; INDOMETACIN; MESSENGER RNA; OLIGONUCLEOTIDE; CCL5 PROTEIN, HUMAN; CELL CYCLE PROTEIN; FRIZZLED PROTEIN; FZD10 PROTEIN, HUMAN; G PROTEIN COUPLED RECEPTOR; GADD45A PROTEIN, HUMAN; LAMA4 PROTEIN, HUMAN; LAMININ; NUCLEAR PROTEIN; PROTEIN BCL 2; PTGS2 PROTEIN, HUMAN; RANTES; TRANSACTIVATOR PROTEIN; VIRUS PROTEIN;

ARTICLE; CARCINOGENESIS; CELL LINE; CELL PROLIFERATION; DNA MICROARRAY; DOWN REGULATION; GENE EXPRESSION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LIVER CELL; MICROARRAY ANALYSIS; MOLECULAR DYNAMICS; NUCLEOTIDE SEQUENCE; PATHOGENESIS; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; UNINDEXED SEQUENCE; UPREGULATION; WESTERN BLOTTING; GENE EXPRESSION PROFILING; GENETICS; LIVER; METABOLISM; PHYSIOLOGY;

CELL CYCLE PROTEINS; CELL LINE; CELL PROLIFERATION; CHEMOKINE CCL5; CYCLOOXYGENASE 2; FRIZZLED RECEPTORS; GENE EXPRESSION PROFILING; HUMANS; LAMININ; LIVER; NUCLEAR PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, G-PROTEIN-COUPLED; TRANS-ACTIVATORS; VIRAL REGULATORY AND ACCESSORY PROTEINS;

EID: 65249093618     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1038/aps.2009.22     Document Type: Article

References (42)

1. Zhang XD, Zhang WY, Ye LH. Pathogenesis of hepatitis B virus infection. Future Virol 2006; 1: 637-47.
2. Feitelson MA, Sun B, Satiroglu Tufan NL, Liu J, Pan J, Lian Z. Genetic mechanisms of hepatocarcinogenesis. Oncogene 2002; 21: 2593-604.
3. Okuda K. Hepatocellular carcinoma. J Hepatol 2000; 32: 225-37.
4. Zhang XD, Zhang H, Ye LH. Efects of hepatitis B virus X protein on the development of liver cancer. J Lab Clin Med 2006; 147: 58-66.
5. Henkler FF, Koshy R. Hepatitis B virus transcriptional activators: mechanisms and possible role in oncogenesis. J Viral Hepat 1996; 3: 109-21.
6. Su JM, Lai XM, Lan KH, Li CP, Chao Y, Yen SH, et al. X protein of hepatitis B virus functions as a transcriptional corepressor on the human telomerase promoter. Hepatology 2007; 46: 402-13.
7. Yun C, Cho H, Kim SJ, Lee JH, Park SY, Chan GK, et al. Mitotic aberration coupled with centrosome amplification is induced by hepatitis B virus X oncoprotein via the Ras-mitogen-activated protein/extracellular signal-regulated kinase-mitogen- activated protein pathway. Mol Cancer Res 2004; 2: 159-69.
8. Zhang XD, Dong N, Zhang H, You JC, Wang HH, Ye LH. Efects of hepatitis B virus X protein on human telomerase reverse transcriptase expression and activity in hepatoma cells. J Lab Clin Med 2005; 145: 98-104.
9. Zhang XD, Dong N, Yin LH, Cai N, Ma HT, You JC, et al. Hepatitis B virus X protein upregulates survivin expression in hepatoma tissues. J Med Virol 2005; 77: 374-81.
10. Ye LH, Dong N, Wang Q, Xu ZL, Cai N, Wang HH, et al. Progressive changes in hepatoma cells stably transfected with hepatitis B virus X gene. Intervirology 2008; 51: 50-8.
11. Huang R, Xing Z, Luan Z, Wu T, Wu X, Hu G. A specifc splicing variant of SVH, a novel human armadillo repeat protein, is up-regulated in hepatocellular carcinomas. Cancer Res 2003; 63: 3775-82.
12. Huang R, Wu T, Xu L, Liu A, Ji Y, Hu G. Upstream binding factor up-regulated in hepatocellular carcinoma is related to the survival and cisplatin-sensitivity of cancer cells. FASEB J 2002; 16: 293-301.
13. Zhang H, Shan CL, Li N, Zhang X, Zhang XZ, Xu FQ, et al. Identification of a natural mutant of HBV X protein truncated 27 amino acids at the COOH terminal and its efect on liver cell proliferation. Acta Pharmacol Sin 2008; 29: 473-80.
14. Wang YD, Chen WD, Wang M, Yu D, Forman BM, Huang W. Farnesoid X receptor antagonizes nuclear factor kappaB in hepatic infammatory response. Hepatology 2008; 48: 1632-43.
15. Wang FZ, Sha L, Ye LH, Zhang XD. Promotion of cell proliferation by HBXIP via upregulation of human telomerase reverse trans-criptase in human mesenchymal stem cells. Acta Pharmacol Sin 2008; 29: 83-9.
16. Lengronne A, Pasero P, Bensimon A, Schwob E. Monitoring S phase progression globally and locally using BrdU incorporation in TK (+) yeast strains. Nucleic Acids Res 2001; 29: 1433-42.
17. Ng RK, Lau CY, Lee SM, Tsui SK, Fung KP, Waye MM. cDNA microarray analysis of early gene expression profiles associated with hepatitis B virus X protein-mediated hepatocarcinogenesis. Biochem Biophys Res Commun 2004; 322: 827-35.
18. Hu Z, Zhang Z, Kim JW, Huang Y, Liang TJ. Altered proteolysis and global gene expression in hepatitis B virus X transgenic mouse liver. J Virol 2006; 80: 1405-13.
19. Lara-Pezzi E, Gómez-Gaviro M V, Gálvez BG, Mira E, Iñiguez MA, Fresno M, et al. The hepatitis B virus X protein promotes tumor cell invasion by inducing membrane-type matrix metallo-proteinase-1 and cyclooxygenase-2 expression. J Clin Invest 2002; 110: 1831-8.
20. Cheng KY, Noble ME, Skamnaki V, Brown NR, Lowe ED, Kontogiannis L, et al. The role of the phospho-CDK2/cyclinA recruitment site in substrate recognition. J Biol Chem 2006; 281: 23167-79.
21. Xu XR, Huang J, Xu ZG, Qian BZ, Zhu ZD, Yan Q, et al. Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncancerous liver. Proc Natl Acad Sci USA 2001; 98: 15089-94.
22. Blackwood EM, Luscher B, Eisenman RN. Myc and max associate in vivo. Genes Dev 1992; 6: 71-80.
23. Collier JJ, Doan T T, Daniels MC, Shurr JR, Kolls JK, Scott DK. c-Myc is required for the glucose-mediated induction of metabolic enzyme genes. J Biol Chem 2003; 278: 6588-95.
24. Kim S, Li Q, Dang CV, Lee LA. Induction of ribosomal genes and hepatocyte hypertrophy by adenovirus-mediated expression of c-Myc in vivo. Proc Natl Acad Sci USA 2000; 97: 11198-202
25. Riu E, Ferre T, Mas A, Hildago A, Franckhauser S, Bosch F. Overexpression of c-myc in diabetic mice restores altered expression of the transcription factor genes that regulate liver metabolism. Biochem J 2002; 368: 931-7.
26. Tompson NL, Mead JE, Braun L, Goyete M, Shank PR, Fausto N. Sequential protooncogene expression during rat liver regeneration. Cancer Res 1986; 46: 3111-7.
27. Ji JF, Wu Y, Zhan Q. Gadd45a function in suppressing cell transformation and tumor malignancy. Prog Biochem Biophys 2006; 12: 1146-53.
28. Zhan Q, Lord K, Alamo IJ, Hollander MC, Carrier F, Ron D, et al. Te gadd and MyD genes defne a novel set of mammalian genes encoding acidic proteins that synergistically suppress cell growth. Mol Cell Biol 1994; 14: 2361-71.
29. Nusse R. Wnt signaling in disease and in development. Cell Res 2005; 15: 28-32.
30. Fujiwara T, Suzuki M, Tanigami A, Ikenoue T, Omata M, Chiba T, et al. Te BTRC gene, encoding a human F-box/WD40-repeat protein, maps to chromosome 10q24-q25. Genomics 1999; 58: 104-5.
31. Nagayama S, Fukukawa C, Katagiri T, Okamoto T, Aoyama T, Oyaizu N, et al. Therapeutic potential of antibodies against FZD10, a cell-surface protein, for synovial sarcomas. Oncogene 2005; 24: 6201-12.
32. Huang X, Ji G, Wu Y, Wan B, Yu L. LAMA4, highly expressed in human hepatocellular carcinoma from Chinese patients, is a novel marker of tumor invasion and metastasis. J Cancer Res Clin Oncol 2008; 134: 705-14.
33. Zlotnik A, Yoshie O. Chemokines: a new classifcation system and their role in immunity. Immunity 2000; 12: 121-7.
34. Tyner JW, Uchida O, Kajiwara N, Kim EY, Patel AC, O'Sullivan MP, et al. CCL5-CCR5 interaction provides antiapoptotic signals for macrophage survival during viral infection. Nat Med 2005; 11: 1180-7.
35. Smith, PC, Hobish A, Lin, D L, Culig Z, Keller ET. Interleukin-6 and prostate cancer progression. Cytokine Growth Factor Rev 2001; 12: 33-40.
36. Kominsky SL, Argani P, Korz D, Evron E, Raman V, Garrett E, et al. Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast. Oncogene 2003; 22: 2021-33.
37. Wiechen K, Diatchenko L, Agoulnik A, Scharff KM, Schober H, Arlt K, et al. Caveolin-1 is down-regulated in human ovarian carcinoma and acts as a candidate tumor suppressor gene. Am J Pathol 2001; 159: 1635-43.
38. Fiucci G, Ravid D, Reich R, Liscovitch M. Caveolin-1 inhibits anchorage independent growth, anoikis and invasiveness in MCF-7 human breast cancer cells. Oncogene 2002; 21: 2365-75.
39. Koga T, Shibahara K, Kabashima A, Sumiyoshi Y, Kimura Y, Takahashi I, et al. Altered proteolysis and global gene expression in hepatitis B virus X transgenic mouse liver. Hepatogastroenterology 2004; 51: 1626-30.
40. Cougot D, Wu Y, Cairo S, Caramel J, Renard CA, Lévy L, et al. The hepatitis B virus X protein functionally interacts with CREB-binding protein/p300 in the regulation of CREB-mediated transcription. J Biol Chem 2007; 282: 4277-87.
41. Rost T, Pyritz V, Rathcke IO, Görögh T, Dünne AA, Werner JA. Reduction of LOX- and LOXL2-mRNA expression in head and neck squamous cell carcinomas. Anticancer Res 2003; 23: 1565-73.
42. Schmidt H, Semjonow A, Csiszar K, Korsching E, Brandt B, Eltze E. Mapping of a deletion interval on 8p21-22 in prostate cancer by gene dosage PCR. Verh Dtsch Ges Pathol 2007; 91: 302-7.